Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients

Early diagnosis of Parkinson’s disease (PD) remains a challenge to date. New evidence highlights the potential clinical value of circulating trace amines (TAs) in early-stage PD and their involvement in disease progression. A new ultra performance chromatography mass spectrometry (UPLC-MS/MS) method...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Andrea, Giovanni, Pizzolato, Gilberto, Gucciardi, Antonina, Stocchero, Matteo, Giordano, Giuseppe, Baraldi, Eugenio, Leon, Alberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467876/
https://www.ncbi.nlm.nih.gov/pubmed/30992490
http://dx.doi.org/10.1038/s41598-019-42535-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467876/
https://www.ncbi.nlm.nih.gov/pubmed/30992490
http://dx.doi.org/10.1038/s41598-019-42535-w

Ejemplares similares